Journal Home
Search for

Volume 13, Issue 1, Pages 21-29 (February 2003)


View previous. 4 of 10 View next.

Oral contraception

Helen Webberley (Career Grade Trainee)f1, Melanie Mann (Consultant in Contraception and Reproductive Health)

Abstract 

An orally administered formulation intended to prevent pregnancy. Oral contraception in women is available in two formulations: products containing both oestrogen and progestogen – combined oral contraceptives (COCs, The Pill) and those containing progestogen alone – progestogen-only pills (POPs, The Mini-Pill).

COCs first became available in the UK in 1961 and have become an extremely safe, effective and popular method of reversible contraception. They also benefit from having non-contraceptive health benefits.

This article aims to outline the advantages and disadvantages of taking oral contraception and important aspects of safe prescribing.

Initially the article will focus on the COC pill, with the differences arising with the progestogen-only pill outlined later.

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

Abstract

References

Copyright

References 

return to Article Outline
FURTHER READING

1. 1 Drug Ther Bull. 2002;40:57–59. MEDLINE | CrossRef

2. 2 Beral V, Hanaford P, Kay C. Oral contraceptive use and malignancies of the genital tract. Lancet. 1988;2:1331–1335. MEDLINE

3. 3 Lancet. 1996;347:1713–1727. Abstract | CrossRef

4. 4 Combined Oral Contraceptives and Cancer. London: RCOG; 2000;.

5. 5 Combined Oral Contraceptives and Migraine. London: RCOG; 2001;.

6. 6 Guillebaud J. Contraception, Your Questions Answered. Edinburgh: Churchill Livingstone; 1993;.

7. 7 Guillebaud J. Contraception, Your Questions Answered. Edinburgh: Churchill Livingstone; 1999;.

8. 8 Huber J, Foidart JM, Wuttke W. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospironone. Eur J Contracept Reprod Health. 2000;5:25–34.

9. 9 Killick S. Contraception in Practice. London: Martin Dunitz; 2000;.

10. 10 Loudon N, Glasier A, Gebbie A. Handbook of Family Planning and Reproductive Healthcare. Edinburgh: Churchill Livingstone; 1995;.

11. 11 Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet. 2001;358:1427–1429. Abstract | Full Text | Full-Text PDF (67 KB) | CrossRef

12. 12 Int J Cancer. 1993;55:228–236. MEDLINE | CrossRef

Sexual Health Service, South Worcestershire Primary Care Trust, Moor Street Clinic, Worcester, Worcestershire, UK

f1 Correspondence to: HW: Tel. +44 (0) 1905 681 639; E-mail: helen@fort-royal.net

PII: S0957-5847(03)90303-9

doi:10.1054/cuog.2003.0303


View previous. 4 of 10 View next.